Sponsor:
Johns Hopkins University
Code:
NCT06116526
Conditions
Atopic Dermatitis
Eligibility Criteria
Sex: All
Age: 1 - 17
Healthy Volunteers: Not accepted
Interventions
Dupilumab - Discontinuation
Dupilumab - Dose Reduction
Dupilumab - Standard Dose
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Johns Hopkins University on 2025-03-25.